Frequent integration of short homologous DNA tracks during Acinetobacter baylyi transformation and influence of transcription and RecJ and SbcCD DNases

Microbiology
Nils Hülter, Wilfried Wackernagel

Abstract

The minimal length of integrated homologous donor DNA tracks in Acinetobacter baylyi transformation and factors influencing the location and length of tracks were determined. Donor DNA contained the nptII gene region (kanamycin resistance, KmR). This region carried nine approximately evenly spaced silent nucleotide sequence tags and was embedded in heterologous DNA. Recipient cells carried the normal nptII gene with a central 10 bp deletion (kanamycin-sensitive). The Km(R) transformants obtained had donor DNA tracks integrated covering on average only 4.6 (2-7) of the nine tags, corresponding to about 60 % of the 959 nt homologous donor DNA segment. The track positions were biased towards the 3' end of nptII. While the replication direction of recipient DNA did not affect track positions, inhibited transcription (by rifampicin) shifted the beginning of tracks towards the nptII promoter. Absence of the RecJ DNase decreased the length of tracks. Absence of SbcCD DNase increased the integration frequency of the 5' part of nptII, which can form hairpin structures of 43-75 nt, suggesting that SbcCD DNase interferes with hairpins in transforming DNA. In homology-facilitated illegitimate recombination events during transformation (in ...Continue Reading

References

Jun 15, 1977·Journal of Molecular Biology·S L Fornili, M S Fox
Jan 5, 1992·Journal of Molecular Biology·A R Rahmouni, R D Wells
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·L F Liu, J C Wang
Feb 1, 1988·Diagnostic Microbiology and Infectious Disease·M SilvaS L Gorbach
Mar 1, 1985·Journal of Bacteriology·G J Warren, R L Green
Jul 11, 1988·Nucleic Acids Research·W J DowerC W Ragsdale
Jul 1, 1966·The Journal of General Physiology·H Ephrussi-Taylor, T C Gray
Feb 28, 1968·Journal of Molecular Biology·T Gurney, M S Fox
Jul 1, 1966·The Journal of General Physiology·W F Bodmer
Jul 1, 1966·The Journal of General Physiology·N Notani, S H Goodgal
Jun 5, 1983·Journal of Molecular Biology·D Hanahan
Jan 1, 1996·Annual Review of Biochemistry·P Modrich, R Lahue
Jan 1, 1996·Annual Review of Biochemistry·J C Wang
Dec 24, 1997·Molecular Microbiology·D R LeachD J Pinder
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·R Friedman-Ohana, A Cohen
Feb 3, 1999·Nucleic Acids Research·J C ConnellyD R Leach
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·F Pasta, M A Sicard
Jun 14, 2000·The Journal of Biological Chemistry·A K Eggleston, S C West
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·J PoglianoD R Helinski
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Johann de Vries, Wilfried Wackernagel
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Marc PrudhommeJean-Pierre Claverys
Jun 26, 2003·Nucleic Acids Research·Michael Zuker
Apr 15, 2004·Nature Reviews. Microbiology·Inês Chen, David Dubnau
Sep 3, 2005·Nature Reviews. Microbiology·Christopher M Thomas, Kaare M Nielsen
Jun 1, 2006·The Journal of Antimicrobial Chemotherapy·William StubbingsIan Chopra
Jul 3, 2007·Journal of Bacteriology·Donald A MorrisonJean-Pierre Claverys

Citations

Mar 2, 2010·Applied Microbiology and Biotechnology·Matthias Brigulla, Wilfried Wackernagel
Oct 29, 2011·IUBMB Life·Kathryn T Elliott, Ellen L Neidle

Related Concepts

SbcC protein, Bacteria
RecJ protein, Bacteria
Mima
Antibiotics
Bacterial Proteins
Alkaline DNase
DNA, Bacterial
Exodeoxyribonuclease
Kantrex
Recombination, Genetic

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.